Opinion

  • AI in medical devices: Why 2026 must be the year cybersecurity catches up

    By Christian Espinosa, CEO & founder, Blue Goat Cyber AI is already reshaping patient care – from faster diagnosis and risk scoring to robotic-assisted surgery and continuous monitoring. But AI in MedTech is moving at startup speed, while security and safety practices are still moving at regulatory speed.   That gap isn’t theoretical. [...]

  • Regulator bans ‘unacceptable’ prostate supplement adverts

    Prostate supplement adverts and home testing kits have been banned by the Advertising Standards Authority (ASA) over concerns they could mislead vulnerable people. The advertising regulator took action against adverts from Nutrisslim, Nutreance, Muxue Trade and Impact Herbs for claiming their products could treat an enlarged prostate, prostate inflammation or urinary flow problems. None of [...]

  • Opinion: How 2025 reshaped digital health innovation

    By Josh Schmidt, partner, BPM After a tumultuous 2023 and 2024, health technology found its footing in 2025—not through a return to boom-time exuberance, but through a more sustainable recalibration driven by artificial intelligence, evolving trial methodologies, and maturing regulatory frameworks. As we approach 2026, the lessons of the past year reveal which innovations are [...]

  • How digital innovation is set to revolutionise ear and hearing health in 2026

    By Dr Krishan Ramdoo, founder and CEO of TympaHealth Despite the fact that hearing loss affects approximately 18 million people in the UK, impacting one in three adults, there remain key barriers in addressing it. According to research by TympaHealth, over one in three (35 per cent) have never had their hearing checked, with 28 [...]

  • Why physician-led outpatient care will be healthcare’s defining trend in 2026 

    By Kristen Richards, vice president of ambulatory care, Cardiovascular Logistics  Anyone working inside or alongside a hospital today can feel that the way we deliver care is reaching a breaking point. Capacity is tight in many regions. Staffing has been a challenge for years. And the volume and complexity of patients continue to increase. [...]

  • Why digital health needs a new kind of revenue leader

    Odgers’ Chris Hamilton and Mike Drew explain what digital health boards should be looking for in commercial leaders Reimbursement has quietly become one of the strongest predictors of commercial success in digital health. Innovation is accelerating and remote care models are expanding, yet many organisations still struggle to convert great products into sustainable revenue. The [...]

  • What does the Autumn Budget mean for NHS technology?

    By Afshin Attari, senior director of public sector at Exponential-e Last week, the government presented its second Autumn Budget. In terms of tech spend, the commitments were relatively low key compared to the previous Budget and the 2025 Spending Review, however there was a much-needed additional cash boost promised to improve NHS patient services. With [...]

  • European healthcare investment in 2026: Outpatient services, optimisation and optimism

    By McDermott Will & Schulte As macro trends such as population growth, ageing demographics, and co-morbidities place increasing pressure on healthcare systems, investors are once again seeking out compelling opportunities in the healthcare services space. Going into 2026, investors are expected to double down on several emerging growth areas. In September 2025, McDermott Will & [...]

  • Why ‘brand’ is the supplement the male fertility market desperately needs

    By Tom Moloney, senior strategy director, Koto Male fertility is entering the mainstream health conversation. Not because men suddenly became proactive about their reproductive health (if only), but because the data is now too loud to ignore. Sperm counts are dropping, awareness is rising, and the market – valued at US$4 billion in 2022 and [...]

  • Opinion: 2025 was a year of correction – 2026 will be the year of construction

    By Sarah Matt, MD, MBA If 2024 was defined by unbridled enthusiasm for Generative AI, 2025 has been a year of necessary and sober recalibration. Over the last twelve months, the healthcare industry moved past the initial excitement to face a more complex reality.   We learned that applying advanced AI to legacy [...]